SCHEMBL4325866

SCHEMBL4325866

CC(=O)Oc1ccc(C=O)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
LMNA P02545 3/20 0.35
DPP4 P27487 1/20 0.33
MAPT P10636 3/20 0.33
CYP3A4 P08684 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
TTR P02766 1/20 0.33
TP53 P04637 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.32
PKM P14618 1/20 0.32
ALOX5 P09917 1/20 0.32
CYP2E1 P05181 1/20 0.32
CYP2A6 P11509 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2B6 P20813 1/20 0.32
CYP2C19 P33261 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38655959 0.81 MEN1 (0.35) ALDH1A1DPP4CYP3A4MEN1KMT2A
SCHEMBL125451 0.75
SCHEMBL27711148 0.75 F2 (0.42) ALDH1A1LMNAMAPTMEN1TP53
SCHEMBL11788283 0.74 LMNA (0.43) ALDH1A1LMNAMAPTCYP3A4KDM4E
SCHEMBL27365753 0.72 CES2 (0.43) ALDH1A1LMNAMAPTCYP3A4KDM4E
SCHEMBL27494352 0.72 LMNA (0.38) ALDH1A1LMNAMAPTCYP3A4KDM4E
SCHEMBL27856627 0.72 LMNA (0.38) ALDH1A1LMNAMAPTCYP3A4KDM4E
SCHEMBL7003234 0.72 F2 (0.42) ALDH1A1LMNAMAPTKDM4EKMT2A
SCHEMBL11450476 0.72 LMNA (0.47) ALDH1A1LMNAMAPTCYP3A4KDM4E
SCHEMBL27492784 0.71 ALDH1A1 (0.37) ALDH1A1DPP4MAPTCYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120118124-A Nitrogen-rich DOPO-based flame retardant, synthesis and application thereof 常州大学 2025-06-10 CN disclosed
US-10167299-B2 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2019-01-01 US disclosed
EP-3091013-B1 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2018-08-08 EP disclosed
US-20170044187-A1 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2017-02-16 US disclosed
US-20170044187-A1 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2017-02-16 US disclosed
EP-3091013-A1 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF Shanghai Institute Of Materia Medica Chinese Academy of Sciences (CN) 2016-11-09 EP disclosed
CN-105358544-A Heterocyclic compound TAKEDA PHARMACEUTICAL 2016-02-24 CN disclosed
WO-2015101265-A1 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 中国科学院上海药物研究所 2015-07-09 WO disclosed
CN-103221047-B Compounds and methods TEMPERO PHARMACEUTICALS INC 2014-12-17 CN disclosed
WO-2009145360-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR R-TECH UENO, LTD. (JP) 2009-12-03 WO disclosed
EP-1791835-A2 THIAZOLE DERIVATIVES HAVING VAP-1 INHIBITORY ACTIVITY Astellas Pharma Inc. (JP) 2007-06-06 EP disclosed
WO-2006028269-A2 THIAZOLE DERIVATIVES HAVING VAP-1 IHIBITORY ACTIVITY ASTELLAS PHARMA INC. (JP) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044187-A1 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF CCR5, CCR1, CCRL2 ALDH1A1 297/4885LMNA 2990/4885DPP4 2082/4885
US-10167299-B2 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof CCR5, CCRL2, CCR1 ALDH1A1 823/4885LMNA 2814/4885DPP4 2118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.